| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.305 | - | 11.119 | 11.771 | 12.315 | 11.897 | 8.748 | 6.609 | 8.855 |
| Total Income - EUR | - | 2.305 | - | 11.119 | 11.771 | 12.315 | 11.897 | 8.748 | 6.609 | 10.138 |
| Total Expenses - EUR | - | 2.245 | - | 9.963 | 4.654 | 3.743 | 1.649 | 1.824 | 3.216 | 8.008 |
| Gross Profit/Loss - EUR | - | 60 | - | 1.155 | 7.117 | 8.572 | 10.248 | 6.925 | 3.393 | 2.130 |
| Net Profit/Loss - EUR | - | -10 | - | 821 | 6.798 | 8.231 | 9.935 | 6.668 | 3.160 | 1.820 |
| Employees | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biorealis Mia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 155 | - | 1.370 | 1.045 | 2.310 | 1.782 | 1.309 | 899 | 704 |
| Current Assets | - | 60 | - | 386 | 6.797 | 6.982 | 17.197 | 5.569 | 5.438 | 4.827 |
| Inventories | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | - | 0 | 849 | 937 | 683 | 688 | 840 | 0 |
| Cash | - | 60 | - | 386 | 5.948 | 6.045 | 16.514 | 4.881 | 4.597 | 4.827 |
| Shareholders Funds | - | 35 | - | 1.006 | 7.785 | 9.212 | 18.942 | 6.811 | 6.016 | 5.083 |
| Social Capital | - | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 181 | - | 750 | 85 | 81 | 37 | 67 | 320 | 449 |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Biorealis Mia Srl